EP3916392
METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS
:
EP einkaleyfi í gildi á Íslandi:
30.5.2017:
1.5.2024:
21170716.1
:
28.5.2024:
15.6.2024
:
29.5.2037:
29.5.2026:
31.5.2026
:
METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS
30.5.2017
1.5.2024
28.5.2024
15.6.2024
29.5.2026
:
Incyte Corporation:
1801 Augustine Cut-Off, Wilmington, DE 19803, US
:
ENDELL, Jan:
80333 München, DE
:
WINDERLICH, Mark:
81373 München, DE
:
BOXHAMMER, Rainer:
83059 Kolbermoor, DE
:
Zacco Denmark A/S:
Arne Jacobsens Allé 15, DK
:
16171885:
30.5.2016:
EP
:
G01N 33/574
: 8
: 4.6.2024
: 29.5.2025
: Árnason Faktor ehf.
: 9
: 30.5.2025
: 29.5.2026
: Árnason Faktor ehf.